NYU Langone Health Bladder Cancer Symposium Update on Medical and Surgical Management for the Urologist 2022

20 $

+ Include: 12 videos + 1 pdf, size: 1.51 GB

+ Target Audience: urologists

Categories: , , , , ,

Description

+ Include: 12 videos + 1 pdf, size: 1.51 GB

+ Target Audience: urologists

+ Sample video: contact me for sample video

+ Information:

March 11, 2022 9:45 AM – 4:30 PM
The diagnosis and management of urothelial cell carcinoma of the bladder have been greatly influenced by recent medical, immunologic, surgical, and technological advances. One of the greatest challenges of the practicing urologist is to stay abreast with the many dynamic changes in this field. A nationally acclaimed faculty has been assembled to provide this update with presentations on topics such as diagnosis and management of non-muscle invasive bladder cancer (NMIBC); novel therapies for high-risk NMIBC including vaccines and clinical trials; immunologic approaches for the treatment of bladder cancer; technical advances in surgical treatment, bladder preservation, and reconstructive surgery. During the plenary sessions and state-of-the-art lectures, the registrants will have the opportunity to participate in question and answer sessions. In addition, an emphasis on case presentations with faculty participation will enhance the practical value of the course.

Course Description

The diagnosis and management of urothelial cell carcinoma of the bladder have been greatly influenced by recent medical, immunologic, surgical, and technological advances. One of the greatest challenges of the practicing urologist is to stay abreast with the many dynamic changes in this field. A nationally acclaimed faculty has been assembled to provide this update with presentations on topics such as diagnosis and management of non-muscle invasive bladder cancer (NMIBC); novel therapies for high-risk NMIBC including vaccines and clinical trials; immunologic approaches for the treatment of bladder cancer; technical advances in surgical treatment, bladder preservation, and reconstructive surgery. During the plenary sessions and state-of-the-art lectures, the registrants will have the opportunity to participate in question and answer sessions. In addition, an emphasis on case presentations with faculty participation will enhance the practical value of the course.
Educational Objectives

After participating in this activity, clinicians should be able to:

  1. Discuss and analyze recent clinical evidence supporting implementing immunotherapy in bladder cancer
  2. Recognize indications and describe best practices for surgical management, reconstruction, and bladder preservation for patients with invasive bladder cancer
  3. Describe new approaches to medical therapy of bladder cancer
  4. Describe similarities and differences of urothelial cell carcinoma of the bladder and upper urinary tract

Target Audience

Urologists and Urologic Trainees (Residents and Fellows)

 

+ Topics:

Agenda.pdf
Bladder Preservation for Muscle Invasive Bladder Cancer.ts
Checkpoint Inhibitors in the Treatment of NMIBC.ts
Complications of Radical Cystectomy Management Strategies.ts
Intravesical BCG Update on State of the Art.ts
Novel Therapies for BCG Unresponsive High Risk NMIBC.ts
Quality Indicators and Enhanced Imaging in Cystoscopy and TURBT Detection.ts
Radical Cystectomy Open Versus Robotic.ts
Treatment of Advanced Metastatic Urothelial Cancer in the Urologist Clinic.ts
Treatment of Locally Advanced Urothelial Cell Carcinoma Neoadjuvant and Adjuvant Therapy.ts
Treatment Surveillance Algorithms AUA NMIBC Guidelines 2020.ts
Update of Upper Tract Urothelial Carcinoma.ts
Updated Treatment of Advanced Metastatic Urothelial Cancer.ts

Reviews

There are no reviews yet.

Be the first to review “NYU Langone Health Bladder Cancer Symposium Update on Medical and Surgical Management for the Urologist 2022”

Your email address will not be published. Required fields are marked *

− 1 = 7
Powered by MathCaptcha

Related products